ロード中...
MRD in AML: The Role of New Techniques
In the context of precision medicine, assessment of minimal residual disease (MRD) has been used in acute myeloid leukemia (AML) to direct individual treatment programs, including allogeneic stem cell transplantation in patients at high-risk of relapse. One of the limits of this approach has been in...
保存先:
| 出版年: | Front Oncol |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6664148/ https://ncbi.nlm.nih.gov/pubmed/31396481 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00655 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|